WO2003082834A3 - Morpholine derivatives and intermediates therefor - Google Patents
Morpholine derivatives and intermediates therefor Download PDFInfo
- Publication number
- WO2003082834A3 WO2003082834A3 PCT/EP2003/003338 EP0303338W WO03082834A3 WO 2003082834 A3 WO2003082834 A3 WO 2003082834A3 EP 0303338 W EP0303338 W EP 0303338W WO 03082834 A3 WO03082834 A3 WO 03082834A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- morpholine derivatives
- intermediates therefor
- amino
- methyl
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003580302A JP2006504626A (en) | 2002-03-28 | 2003-03-27 | Morpholine derivatives and intermediates thereof |
EP03745295A EP1490345A2 (en) | 2002-03-28 | 2003-03-27 | Novel compound |
AU2003226758A AU2003226758A1 (en) | 2002-03-28 | 2003-03-27 | Morpholine derivatives and intermediates therefor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0207447.4 | 2002-03-28 | ||
GBGB0207447.4A GB0207447D0 (en) | 2002-03-28 | 2002-03-28 | Novel compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003082834A2 WO2003082834A2 (en) | 2003-10-09 |
WO2003082834A3 true WO2003082834A3 (en) | 2004-03-25 |
Family
ID=9933997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/003338 WO2003082834A2 (en) | 2002-03-28 | 2003-03-27 | Morpholine derivatives and intermediates therefor |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1490345A2 (en) |
JP (1) | JP2006504626A (en) |
AR (1) | AR039176A1 (en) |
AU (1) | AU2003226758A1 (en) |
GB (1) | GB0207447D0 (en) |
TW (1) | TW200401771A (en) |
WO (1) | WO2003082834A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0243959A1 (en) * | 1986-04-30 | 1987-11-04 | Dainippon Pharmaceutical Co., Ltd. | Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same |
WO1995031431A1 (en) * | 1994-05-18 | 1995-11-23 | Nisshin Flour Milling Co., Ltd. | Novel diaminomethylidene derivative |
WO1995031442A1 (en) * | 1994-05-18 | 1995-11-23 | Nisshin Flour Milling Co., Ltd. | Novel pyrimidine derivative |
WO1998056771A2 (en) * | 1997-06-12 | 1998-12-17 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
WO2002026723A1 (en) * | 2000-09-29 | 2002-04-04 | Glaxo Group Limited | Compounds useful in the treatment of inflammatory diseases |
-
2002
- 2002-03-28 GB GBGB0207447.4A patent/GB0207447D0/en not_active Ceased
-
2003
- 2003-03-26 TW TW092106774A patent/TW200401771A/en unknown
- 2003-03-27 WO PCT/EP2003/003338 patent/WO2003082834A2/en not_active Application Discontinuation
- 2003-03-27 AR ARP030101089A patent/AR039176A1/en unknown
- 2003-03-27 EP EP03745295A patent/EP1490345A2/en not_active Withdrawn
- 2003-03-27 AU AU2003226758A patent/AU2003226758A1/en not_active Abandoned
- 2003-03-27 JP JP2003580302A patent/JP2006504626A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0243959A1 (en) * | 1986-04-30 | 1987-11-04 | Dainippon Pharmaceutical Co., Ltd. | Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same |
WO1995031431A1 (en) * | 1994-05-18 | 1995-11-23 | Nisshin Flour Milling Co., Ltd. | Novel diaminomethylidene derivative |
WO1995031442A1 (en) * | 1994-05-18 | 1995-11-23 | Nisshin Flour Milling Co., Ltd. | Novel pyrimidine derivative |
WO1998056771A2 (en) * | 1997-06-12 | 1998-12-17 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
WO2002026723A1 (en) * | 2000-09-29 | 2002-04-04 | Glaxo Group Limited | Compounds useful in the treatment of inflammatory diseases |
Non-Patent Citations (1)
Title |
---|
SARTORI E ET AL: "SYNTHESIS AND ACTIVITIES OF NET ARYLSULFONAMIDO THROMBOXANE A2 RECEPTOR ANTAGONISTS", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 28, no. 7/8, 1993, pages 625 - 632, XP000396678, ISSN: 0223-5234 * |
Also Published As
Publication number | Publication date |
---|---|
JP2006504626A (en) | 2006-02-09 |
TW200401771A (en) | 2004-02-01 |
AR039176A1 (en) | 2005-02-09 |
AU2003226758A1 (en) | 2003-10-13 |
GB0207447D0 (en) | 2002-05-08 |
EP1490345A2 (en) | 2004-12-29 |
WO2003082834A2 (en) | 2003-10-09 |
AU2003226758A8 (en) | 2003-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ502702A (en) | Amide derivatives for the treatment of diseases mediated by TNF, IL-1, IL-6 or IL-8 | |
WO2004016578A3 (en) | Arylethanolamine beta2-adrenoreceptor agonist compounds | |
NZ514234A (en) | N-cyanomethylamides as protease inhibitors | |
DK1682503T3 (en) | Derivatives of N- (phenyl1 / alkylpiperdin-2-yl) methyl) benzamide, preparation and use thereof in therapy | |
WO2002010154A3 (en) | Substituted heterocyclic amides | |
HK1080856A1 (en) | Compounds having selective inhibiting effect at gsk3 | |
EP1741712A3 (en) | Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of Nebivolol | |
AU2055500A (en) | Aromatic amides | |
FI950309A0 (en) | proline amide derivative | |
ATE326453T1 (en) | ANTITHRBOTIC AMIDES | |
MXPA04004548A (en) | Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors. | |
FR2861070B1 (en) | DERIVATIVES OF N- [PHENYL (PYRROLIDIN-2-YL) METHYL] BENZAMIDE AND N - [(AZEPAN-2-YL) PHENYLMETHYL] BENZAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
HUP0302553A2 (en) | Salts of a isothiazole-4-carboxamide and process for their preparation and use for the preparation of anti-hyperproliferation agents | |
AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
AU2364000A (en) | Heterocyclic amides as inhibitors of factor xa | |
DE60035429D1 (en) | USE OF SULFODE HYDROABETIC ACIDS FOR THE TREATMENT OF INFLAMMATORY ENDURANCE | |
MXPA04005484A (en) | Method for preparing echinocandin derivatives. | |
AR039177A1 (en) | MORFOLINA DERIVATIVES, CCR3 ANTAGONISTS. | |
WO2003082834A3 (en) | Morpholine derivatives and intermediates therefor | |
ZA959311B (en) | 5-(aryloxymethyl)oxazolines a process for the preparation thereof and pharmaceutical compositions containing them | |
ZA200300218B (en) | Novel N-(2-phenyl-3-aminopropyl)naphtamides. | |
SE9900190D0 (en) | New compounds | |
BR0214780A (en) | Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof | |
HK1073112A1 (en) | 3-(Cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003580302 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003745295 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003745295 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003745295 Country of ref document: EP |